Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rectal Neoplasms × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Insulin Resistance 2 Inflammation 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Weight Gain 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1

Interventions

Oxaliplatin 233 Fluorouracil 231 Capecitabine 185 Leucovorin 183 Irinotecan 131 Radiotherapy 115 Bevacizumab 95 Cetuximab 67 Folfox protocol 45 Surgical Procedures, Operative 41 Neoadjuvant Therapy 36 Drug Therapy 36 Radiation 35 Chemoradiotherapy 32 Chemotherapy, Adjuvant 31 Panitumumab 24 XELOX 22 Radiotherapy, Intensity-Modulated 19 Floxuridine 16 Magnetic Resonance Spectroscopy 14 pembrolizumab 13 IFL protocol 13 trifluridine tipiracil drug combination 12 Nivolumab 12 Erlotinib Hydrochloride 12 Early Intervention, Educational 12 dehydroftorafur 11 Laparoscopy 11 Immunohistochemistry 11 Consolidation Chemotherapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04503694 2025-03-05

REGINA

Jules Bordet Institute

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡